Cargando…
Estimating the budget impact of orphan medicines in Europe: 2010 - 2020
BACKGROUND: Orphan drugs are a growing issue of importance to European healthcare policy makers. The success of orphan drug legislation in Europe has resulted in an increasing number of licensed medicines for rare diseases, and many more yet unlicensed products have received orphan drug designation....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191371/ https://www.ncbi.nlm.nih.gov/pubmed/21951518 http://dx.doi.org/10.1186/1750-1172-6-62 |